Gentian Diagnostics Investor Relations Material
Latest events
Q4 2023
Gentian Diagnostics
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Gentian Diagnostics
Access all reports
Segment Data
Access more data
Sales by
Geography
Europe
Asia
U.S.
Expenses by
Financials
Gentian Diagnostics ASA develops, manufactures, and markets biochemical reagents for use in clinical diagnostics and research. The company offers over 400 products for the detection of all important blood groups, antibodies, pregnancy testing, cytology and histopathology. All products are made by means of advanced manufacturing systems developed by Gentian and its strategic partner Beckman Coulter Inc. The company was incorporated in 2001 and is headquartered in Moss, Norway.
Key slides for Gentian Diagnostics
Q4 2023
Gentian Diagnostics
Q4 2023
Gentian Diagnostics
Latest articles
Sundar Pichai: CEO of Alphabet and Google
Explore Sundar Pichai's improbable journey from Chennai, India, to becoming one of the most powerful individuals on the planet.
19 Apr 2024
The Three Cornerstones of Serial Acquirer Success
Explore what is behind successful serial acquirers: efficient capital use, decentralization, and a strong focus on people.
19 Apr 2024
Companies That Had Their IPO in 2023: Cautious Optimism
The cautiously optimistic market in 2023 saw stocks rebounded upwards, and interest in IPOs picked up from the previous year.
15 Apr 2024
Ticker symbol
Country
🇳🇴 Norway